financial results

Village Farms International (VFF) will release its third quarter 2025 financial results on Monday, November 10, 2025, at 7:00 a.m. ET. A conference call and webcast will follow at 8:30 a.m. ET that day, focusing on the results and featuring a Q&A session. The company’s diversification strategy, including cannabis operations and renewable natural gas production, will likely be discussed. A replay of the call will be available on the investor relations website. Advance registration is required for telephone participation.

American Riviera Bancorp (OTCQX: ARBV) reported a net income of $2.9 million ($0.51/share) for Q3 2025 and $7.9 million ($1.38/share) for the nine months ended September 30, 2025. Total deposits rose 11.3% to $1.26 billion, and total loans increased 6.7% to $1.04 billion. The net interest margin was 3.66%. While on-balance sheet liquidity remained strong and tangible book value increased, non-accrual loans notably rose to $9.8 million. The company repurchased 100,000 shares and plans expansion into Ventura County.

Autohome Inc. (ATHM; 2518.HK) will release its Q3 2025 financial results on November 6, 2025, before U.S. markets open. A conference call will be held at 7:00 AM ET. Analysts are focusing on the company’s performance in a changing Chinese automotive market, including the effectiveness of its AI content strategy and the success of Autohome Mall. A live and archived webcast will be available at https://ir.autohome.com.cn. Autohome is adapting to increased EV adoption and competition, striving to diversify its revenue beyond advertising.

Pharming Group will report its Q3 2025 financial results and provide a business update on November 6th. Investors will focus on Ruconest® performance amid competitive HAE therapies and Pharming’s ability to maintain market share. The update will detail R&D pipeline progress, strategic initiatives including collaborations/acquisitions, and capital allocation. Analysts anticipate insights into revenue growth, expense management, and pipeline advancement’s impact on investor sentiment and future prospects. Guidance on full-year performance and strategic priorities will also be closely watched.

Peakstone Realty Trust (NYSE: PKST) will release its Q3 2025 financial results on November 5, 2025, after market close, followed by a live webcast at 5:00 p.m. ET to discuss the results and its strategic shift towards the Industrial Outdoor Storage (IOS) sector. The company is actively reshaping its portfolio to capitalize on the growing demand for IOS facilities. Investors and analysts can access the webcast via the company’s investor relations website, with a replay available afterwards. Dial-in access is also provided.

Middlefield Banc Corp (MBCN) reported strong results for the nine months ended September 30, 2025. Q3 highlights include diluted EPS of $0.65, a 37.3% increase in pre-tax, pre-provision earnings to $6.8 million, and a net interest margin of 3.79%. Total loans reached a record $1.61 billion and total assets $1.98 billion. Year-to-date diluted EPS was $2.01, and book value rose to $27.71 per share. Management cited loan growth, margin expansion, and a one-time real estate gain, while addressing a small portfolio of problem loans.

Mesoblast (MESO) reported Q1 FY2026 results with cell therapy revenue of $20.6M, up from $12.9M sequentially. Ryoncil gross sales rose 66% to $21.9M; net sales increased 69% to $19.1M after adjustments. A permanent Ryoncil J-code (J3402) became active 10/1/25 and federal Medicaid coverage is mandatory from 7/1/25. The company held $145M cash and secured convertible note agreements for up to $50M (subject to approval). They onboarded 40 transplant centers with coverage over 260M lives.

Delcath Systems, Inc. announced preliminary Q3 2025 results, with total CHEMOSAT and HEPZATO KIT revenue reaching $20.5 million and net income at $0.8 million. The company projects full-year revenue between $83 and $85 million, representing a 150% treatment volume increase. Positive adjusted EBITDA and operating cash flow are anticipated for each quarter of 2025. A conference call is scheduled for October 20 to discuss results and the CHOPIN trial. The company focuses on liver cancer therapies, including HEPZATO KIT and CHEMOSAT.

Sify Technologies (NASDAQ: SIFY) will release its Q2 FY2025-2026 financial results on October 25, 2025, before market open. A conference call to discuss results will be held on October 27, 2025, at 8:30 AM ET, hosted by Raju Vegesna and M P Vijay Kumar. Sify, a leading Indian ICT solutions provider, focuses on data centers, cloud, networks, and security, catering to India’s digital economy. Webcast and replay details are available on Sify’s website.

Otter Tail Corporation (Nasdaq: OTTR) will release its Q3 2025 financial results on November 3, 2025, after market close. A conference call and live webcast analyzing the results will be held on November 4, 2025, at 10:00 a.m. CT. Investors and analysts are focused on the company’s performance amid changing energy regulations, commodity prices, and renewable energy demand, as well as its manufacturing segment’s performance. Webcast details and accompanying slides are available at www.ottertail.com/events-and-presentations.